Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-PROT-101

ABSTRACT: Biomarkers discovery for Colorectal cancer

PROVIDER: E-PROT-101 | ExpressionAtlas | 2023-06-21

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-PROT-101-MappedToGeneID.txt	Txt
	E-PROT-101-MaxQuant_Summary_ExpressionAtlas_LabelFree_Rmarkdown.pdf	Pdf
	E-PROT-101-analysis-methods.tsv	Tabular
	E-PROT-101-configuration.xml	Xml
	E-PROT-101-factors.xml	Xml

Items per page:

1 - 5 of 11

Similar Datasets

E-PROT-100

Project description:Biomarkers discovery for Colorectal cancer liver metastasis

2023-06-21 | E-PROT-100 | ExpressionAtlas

E-PROT-107

Project description:Identification and validation of stage-associated serum biomarkers in colorectal cancer stages.

2023-06-21 | E-PROT-107 | ExpressionAtlas

Tissue and blood microRNA array profiles of colorectal cancer patients

Project description:microRNAs (miRNAs) are short, non-coding RNA molecules that act as regulators of gene expression. Circulating blood miRNAs offer great potential as cancer biomarkers. The objective of the study was to correlate the differential expression of miRNAs in tissue and blood in the identification of biomarkers for early detection of colorectal cancer (CRC). miRNA biomarker discovery via miRNA array profiling using paired cancer tissues (n = 30) and blood samples (CRC, n = 42; control, n = 18).

2013-12-30 | E-GEOD-39845 | biostudies-arrayexpress

Methylation analysis of serum cfDNA pooled samples for the discovery of non-invasive biomarkers for colorectal cancer

Project description:We explored the differential methylation patterns found in cfDNA between no neoplasia (NN; individuals with no colorectal findings, benign pathologies and non-advanced adenomas) and patients with advanced neoplasia (AN; advanced adenomas and colorectal cancer) using pooled samples, for the discovery of non-invasive methylation biomarkers for CRC screening. cfDNA was extracted from serum samples and methylation measurements were assessed with the Infinium MethylationEPIC BeadChip. Data was mainly preprocessed and analyzed with R/Bioconductor packages.

2023-10-01 | GSE186381 | GEO

Identification of autoantibodies in colorectal cancer

Project description:Colorectal cancer remains the leading cause of cancer death worldwide. The 5-year annual survival is less than half of the incidence rate that is predominantly due to late diagnosis of the disease striking the very urgent clinical necessity for biomarkers capable of detecting cancer malignancy at an early onset. During neoplastic transformation, cells undergo several behavioral changes that subsequently result in defects in cell division, immune tolerance, inflammation, and cellular death mechanisms. These processes lead to the development of tumor antigens (TA) that evoke an immune response and subsequent generation of antibodies against self-proteins, called autoantibodies (AAbs). This study aims to identify autoantibody biomarkers in patient’s sera for early screening of the cancer. High-density human proteome array having approximately 17,000 full-length recombinant human proteins were used in the study. The generation of an autoimmune response against important cancer-linked pathways could be important in terms of screening for the disease. The process of immune surveillance starts as tumorigenesis begins and hence autoantibodies can be detected in a very early stage of cancer. Moreover, AAbs can be easily extracted from blood serum through the least invasive test for disease screening.

2022-12-07 | E-MTAB-12081 | biostudies-arrayexpress

Discovery of lncRNA biomarkers of prostate cancer

Project description:Discovery of lncRNA biomarkers of prostate cancer

| PRJNA474912 | ENA

E-PROT-18

Project description:Colorectal cancer cell line proteomes

2021-05-25 | E-PROT-18 | ExpressionAtlas

Homo sapiens

Project description:Discovery of salivary transcriptomic biomarkers for ovarian cancer

| PRJNA140075 | ENA

Transcription profiling of rectal adenocarcinomas biopsied before and after pre-operative short-course radiotherapy or 5-flurouracil-based chemoradiotherapy

Project description:The molecular mechanisms of clinical response or resistance to therapy were evaluated in colorectal cancer patients in a prospective biomarker discovery project. Rectal adenocarcinomas, biopsied before (diagnostic biopsy) and after (surgical resection) pre-operative short-course radiotherapy [RT] or 5-flurouracil (5-FU)-based chemoradiotherapy [CRT], were profiled using Affymetrix HGU133 Plus 2.0 microarrays. Tumour tissues from untreated controls at diagnosis and surgical resection were used to identify treatment-independent gene expression changes. Candidate resistance biomarkers were identified in this pilot study for validation in a larger cohort.

2009-11-10 | E-MEXP-1901 | biostudies-arrayexpress

DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer

Project description:DNA methylation in colorectal cancer diagnosis. The Illumina GoldenGate Methylation Cancer Panel I was used to select a set of candidates markers informative of colorectal cancer diagnosis from 807 cancer-related genes. In the discovery phase, tumor tissue and paired adjacent normal mucosa from 92 colorectal patients were analyzed.

2013-05-27 | GSE43369 | GEO